Drug industry to visualize R&D investment for Chinese market.

Published: 2002-11-26 06:57:00

Updated: 2002-11-26 06:57:00

20 leading pharmaceutical companies have visualized their business entry into China including R&D plans in association with NHTP, a Chinese national class of health and science industrial park.

The Korea New Drug Development Association dispatched 25 delegates representing to 20 Association me...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK